TOP1630

· Topivert Pharma Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TOP1630, covering 2019-08-07 to 2024-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of TOP1630 for Dry Eye Syndrome [Phase 2]